The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report
Open accessAbstract
Rationale: Fecal microbiota transplantation (FMT) is recognized as an emerging treatment through reconstruction of gut microbiota. Parkinson's disease is a neurodegenerative disorder, which is accompanied by constipation. Here we first reported a patient with Parkinson's disease and constipation that were obviously relieved after FMT. Patient concerns: A 71-year-old male patient presented with 7 years of resting tremor, bradykinesia (first inflicted the upper limbs and subsequently spread to lower limbs), and intractable constipation (defecation needing more than 30 minutes). Diagnoses: Parkinson's disease for 7 years; constipation >3 years. Interventions: The patient had used madopar, pramipexole, and amantadine for anti-Parkinson and showed partially mitigation while laxative therapy for constipation failed. Finally FMT was performed. Outcomes: The patient successfully defecated within 5 minutes and maintained daily unobstructed defecation until the end of follow-up. The patient's tremor in legs almost disappeared at 1 week after FMT but recurred in the right lower extremity at 2 months after FMT. Lessons: Gut microbiota reconstruction may have therapeutic effects for Parkinson's disease patients, especially those who have gastrointestinal symptoms and limited treatment choices.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Subsequent clinical trials have indicated that cognitive and behavioural improvements could be achieved through fecal microbiota transplantation (FMT) in patients with mild cognitive impairment as well as those suffering from PD.76,77”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [77]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One case study conducted in 2019 by Huang et al. investigated the potential therapeutic benefit of FMT in a 71-year-old male PD patient reporting constipation (>3 years) and motor symptoms (for 7 years). While FMT successfully promoted regular defecation, tremor disappeared only temporarily and then reappeared two months after transplant [474].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [474]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A clinical study reported that constipation and movement symptoms were significantly relieved after a single FMT treatment in a patient with Parkinson's disease with constipation, and leg tremor almost disappeared 1 week after FMT treatment.277”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [277]
Experimental — accuracy not yet measuredIn the citing paper
“Concerning PD, consistent preclinical studies and a handful of human case reports have shown that FMT might be exploited to reduce motor and non-motor symptoms, as well as constipation, at least in the short term [40,465,469,470,471,472,473,474,475,476,477] (Table 4).”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [474]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572 · cited 9×
“FMT= fecal microbiota transplantation, PAC-QOL=patient-assessment of constipation quality of life, UPDRS=unified Parkinson’s disease rating scale. of “gut microbiota-brain axis” has been well established and its dysregulation may lead to neurological disease like PD.[2] Accumulating evidence indicates a potential bidi…”
BackgroundInfluentialGut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622 · cited 10×
“Moreover, aSyn-overexpressing mice implanted with microbiota from PD-affected patients showed more obvious physical impairment compared to those with microbiota from healthy human donors.([3]) Fecal microbiota transplantation (FMT), a technology by transplanting the gut microbiota of healthy people into the patients’…”
BackgroundInfluentialStages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689 · cited 2×
“Braak et al[15,16] inferred that the gastrointestinal plexus was involved in the early onset of PD. Svensson et al[17] verified that cutting off the abdomen significantly reduced the prevalence of PD, which meant the intestinal activity may associate with PD. Treating PD with FMT has just taken a baby step, but it is…”
BackgroundGut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · cited 2×
“Second, Scheperjans’s([13]) sequencing of 72 stool samples from PD patients and healthy controls found the abundance of Prevotella in PD patients decreased significantly.”
BackgroundMoayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354 · cited 2×
“Braak et al[15,16] inferred that the gastrointestinal plexus was involved in the early onset of PD. Svensson et al[17] verified that cutting off the abdomen significantly reduced the prevalence of PD, which meant the intestinal activity may associate with PD. Treating PD with FMT has just taken a baby step, but it is…”
BackgroundColonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281 · cited 2×
“Keshavarzian et al([14]) found the abundance of butyric acid-producing bacteria such as Blautia, Coprococcus, and Roseburia reduced in PD patients.”
BackgroundA constipation scoring system to simplify evaluation and management of constipated patients
Agachan, F., Chen, T., Pfeifer, J., Reissman, P., & Wexner, S. D. (1996) · Diseases of the Colon & Rectum · doi:10.1007/bf02056950 · Cited by 1,253 · cited 1×
“Patient-assessment of constipation quality of life (PAC-QOL score),([7]) and Wexner constipation score,([8]) 18 and 16.”
BackgroundVagotomy and subsequent risk of Parkinson's disease
Svensson, E., Horváth‐Puhó, E., Thomsen, R. W., Djurhuus, J. C., Pedersen, L., Borghammer, P., & Sørensen, H. T. (2015) · Annals of Neurology · doi:10.1002/ana.24448 · Cited by 806 · cited 2×
“Braak et al[15,16] inferred that the gastrointestinal plexus was involved in the early onset of PD. Svensson et al[17] verified that cutting off the abdomen significantly reduced the prevalence of PD, which meant the intestinal activity may associate with PD. Treating PD with FMT has just taken a baby step, but it is…”
BackgroundThe Enteric Network: Interactions between the Immune and Nervous Systems of the Gut
Yoo, B. B., & Mazmanian, S. K. (2017) · Immunity · doi:10.1016/j.immuni.2017.05.011 · Cited by 474 · cited 1×
“As a potential modulator of human biology, gut microbiota can directly or indirectly regulate brain neurochemistry through immune, metabolic, or endocrine mechanisms.([11]) PD is a huge concern for the aging population.”
Background
Cited by
Chen, Y., Xu, J., & Chen, Y. (2021) · Nutrients · doi:10.3390/nu13062099 · Cited by 917
Zhao, Z., Ning, J., Bao, X.-Q., Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Microbiome · doi:10.1186/s40168-021-01107-9 · Cited by 616
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders
Sorboni, S. G., Moghaddam, H. S., Jafarzadeh-Esfehani, R., & Soleimanpour, S. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00338-20 · Cited by 522
Fecal Microbiota Transplantation in Neurological Disorders
Vendrik, K. E. W., Ooijevaar, R. E., de Jong, P. R. C., Laman, J. D., van Oosten, B. W., van Hilten, J. J., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Contarino, M. F. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00098 · Cited by 413
Suganya, K., & Koo, B.-S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207551 · Cited by 368
Metadata
- Authors
- Huang, H., Xu, H., Luo, Q., He, J., Li, M., Chen, H., Tang, W., Nie, Y., & Zhou, Y.
- Affiliations
- Guangzhou First People's Hospital (CN)
- Department of Gastroenterology, Guangzhou Digestive Disease Center
- Corresponding author
- Nie, Yuqiang
- Zhou, Yongjian
- Venue
- Medicine
- Published
- 2019-06
- Volume
- 98
- Issue
- 26
- Pages
- e16163
- ISSN
- 0025-7974 (ISSN-L)
- 1536-5964
- PMC
- PMC6616439
- OpenAlex
- W2953625730
- Semantic Scholar
- 853b24b882e8fd421790483a2091e3846eb9b274
- Cited by
- 201
- References
- 17
- Citations by year
- 2026: 14 · 2025: 32 · 2024: 36 · 2023: 21 · 2022: 39 · 2021: 45 · 2020: 13 · 2019: 1
- FWCI
- 16.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Medicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81871905, 201904010132)
- Natural Science Foundation of Guangdong Province (2018A030313676, 201904010132)
- Guangzhou First People's Hospital
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- fecal microbiota transplantation, Parkinson's disease, constipation, gut microbiota, neurodegenerative diseases, tremor, bradykinesia, laxative therapy, antiparkinsonian drugs, gastrointestinal symptoms
- MeSH terms
- Fecal Microbiota Transplantation, Aged, Constipation, Humans, Male, Parkinson Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report. https://app.cochat.ai/papers/10.1097/md.0000000000016163
- The paper
- Huang, H., Xu, H., Luo, Q., He, J., Li, M., Chen, H., Tang, W., Nie, Y., & Zhou, Y. (2019). Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report. Medicine. https://doi.org/10.1097/md.0000000000016163
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.